先駆け審査指定制度対象品目の募集 against Baiozienziyapan K.K.
バイオジェン・ジャパン株式会社 (薬事法)
薬事法Ministry of Health, Labour and WelfareOctober 5, 2017
Action summary
- Company
- Baiozienziyapan K.K.RomanizedOriginal: バイオジェン・ジャパン株式会社Corporate Number: 7010401046394
- Governing law
- 薬事法薬事法
- Action type
- 先駆け審査指定制度対象品目の募集先駆け審査指定制度対象品目の募集
- Action date
- October 5, 2017
- Issuing authority
- Ministry of Health, Labour and Welfare厚生労働省
Violation
Machine-translated summary — verify against original
Aducanumab for the suppression of Alzheimer's disease progression
Show original Japanese text
aducanumab アルツハイマー病の進行抑制
Source
Original Ministry of Health, Labour and Welfare announcement (in Japanese)The original Japanese disclosure is the authoritative record.
Watch this company
Get an email when Baiozienziyapan K.K. has new enforcement actions or registry changes (representative, address, business status). Sign-in is via a one-time email link — no password.
Language
日本語版を見る (Japanese)Company info
- English name
- Baiozienziyapan K.K. Romanized
- Japanese name
- バイオジェン・ジャパン株式会社
- Corporate Number
- 7010401046394
- Registered address
- 東京都中央区日本橋１丁目４番１号日本橋一丁目三井ビルディング１４Ｆ
About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.